[The new class of drugs-- metalloprotease inhibitors -- in the treatment of heart failure].
Berezin
A E
AE
D006020:Glycopeptides / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D007189:Indans / Q000627:therapeutic use; D045726:Metalloproteases / Q000037:antagonists & inhibitors*; D011422:Propionates / Q000627:therapeutic use; D011480:Protease Inhibitors / Q000145:classification / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use; D013841:Thiazepines / Q000627:therapeutic use; D015244:Thiorphan / Q000627:therapeutic use
D006020:Glycopeptides; D007189:Indans; D011422:Propionates; D011480:Protease Inhibitors; D011725:Pyridines; D013841:Thiazepines; C106266:omapatrilat; C062766:candoxatril; D015244:Thiorphan; D045726:Metalloproteases; C008890:phosphoramidon